Holen Sie sich die Stockscreener-App
4.19
3.20%
0.13
Handel nachbörslich:
4.17
-0.02
-0.48%
Cytomx Therapeutics Inc Aktie (CTMX) Neueste Nachrichten
Can CytomX Therapeutics Stock Recover If Markets Fall? - Trefis
What analysts say about CytomX Therapeutics Inc stockVolume Weighted Average Price & Explosive Profit Potential - earlytimes.in
With CytomX Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
What Analysts Think Is Changing the CytomX Therapeutics Story After Recent Cancer Developments - Yahoo Finance
CytomX Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of key data By Investing.com - Investing.com South Africa
CytomX Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of key data - Investing.com UK
Is CytomX Therapeutics Inc. stock a contrarian buyJuly 2025 PostEarnings & Technical Confirmation Alerts - Newser
Will CytomX Therapeutics Inc. stock beat EPS estimatesMarket Performance Report & Reliable Breakout Forecasts - Newser
Is CytomX Therapeutics Inc. (6C1) stock suitable for passive index funds2025 Earnings Surprises & Safe Entry Momentum Tips - Newser
Why CytomX Therapeutics Inc. (6C1) stock is listed among top recommendationsTrade Entry Report & High Accuracy Trade Alerts - Newser
Is CytomX Therapeutics Inc. (6C1) stock attractive post correctionProduct Launch & Real-Time Stock Movement Alerts - Newser
Published on: 2025-12-04 14:11:00 - Newser
Will CytomX Therapeutics Inc. (6C1) stock sustain dividend payoutsJuly 2025 Sector Moves & Verified Short-Term Plans - Newser
Would You Still Hold CytomX Therapeutics Stock If It Fell Another 30%? - Trefis
CytomX Therapeutics (NASDAQ:CTMX) Trading Down 6.5%What's Next? - MarketBeat
Is CytomX Therapeutics Inc. (6C1) stock ideal for retirement investorsJuly 2025 Patterns & Fast Gain Stock Trading Tips - Newser
What insider purchases suggest about CytomX Therapeutics Inc. (6C1) stockFed Meeting & Fast Gain Stock Trading Tips - Newser
Is CytomX Therapeutics Inc. (6C1) stock a buy on weaknessQuarterly Trade Summary & Fast Entry High Yield Tips - Newser
Will CytomX Therapeutics Inc. (6C1) stock outperform Dow JonesSell Signal & High Return Stock Watch Alerts - Newser
How CytomX Therapeutics Inc. (6C1) stock reacts to weak economy2025 Price Targets & Entry Point Confirmation Alerts - Newser
Portfolio Shifts: Is CytomX Therapeutics Inc 6C1 stock undervalued by metricsWeekly Loss Report & Daily Technical Stock Forecast Reports - BỘ NỘI VỤ
Will CytomX Therapeutics Inc. (6C1) stock benefit from infrastructure billWeekly Volume Report & High Conviction Buy Zone Picks - Newser
Why CytomX Therapeutics Inc. (6C1) stock is a strong buy callQuarterly Profit Report & Daily Market Momentum Tracking - Newser
What analyst consensus says on CytomX Therapeutics Inc. stockMarket Performance Summary & Risk Managed Trade Strategies - Newser
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
CapEx per share of CytomX Therapeutics, Inc. – DUS:6C1 - TradingView
Revenue per share of CytomX Therapeutics, Inc. – DUS:6C1 - TradingView
Operating cash flow per share of CytomX Therapeutics, Inc. – DUS:6C1 - TradingView
Is CytomX Therapeutics Inc. stock a top pick in earnings seasonJuly 2025 Decliners & Real-Time Volume Analysis Alerts - moha.gov.vn
Franklin Resources Inc. Invests $13.10 Million in CytomX Therapeutics, Inc. $CTMX - MarketBeat
CytomX Therapeutics jumps 54% after Q1 beat, prices $100M offering - MSN
CTMX (CytomX Therapeutics) Other Income (Minority Interest) : $0.0 Mil (TTM As of Sep. 2025) - GuruFocus
CX-2051 Momentum and An Expanding Oncology Pipeline Strengthen CytomX Therapeutics’ (CTMX) Investment Case - Insider Monkey
Will CytomX Therapeutics Inc. stock recover faster than peers2025 Historical Comparison & Fast Entry High Yield Tips - moha.gov.vn
Is CytomX Therapeutics Inc. (6C1) stock attractive for dividend growthJuly 2025 Snapshot & Technical Pattern Based Buy Signals - moha.gov.vn
Can CytomX Therapeutics Inc. stock sustain free cash flow growth2025 Price Targets & Weekly Watchlist for Hot Stocks - BỘ NỘI VỤ
Will CytomX Therapeutics Inc. stock split attract more investors2025 Key Lessons & Long-Term Growth Portfolio Plans - moha.gov.vn
ON Partners Recruits Chief Business Officer for CytomX Therapeutics - Hunt Scanlon Media
CytomX Therapeutics to Present at Upcoming December Investor Conferences - The Manila Times
CytomX Therapeutics (NASDAQ: CTMX) joins Evercore, Piper Sandler healthcare investor conferences in December - Stock Titan
Why Analysts Say the CytomX Story Is Evolving After Recent Clinical Momentum and Price Target Hike - Yahoo Finance
CytomX Therapeutics (CTMX) Price Target Increased by 15.12% to 7.21 - MSN
CytomX Therapeutics Inc Stock Analysis and ForecastVolume Profile Analysis & Superior Portfolio Investment - earlytimes.in
Will CytomX Therapeutics Inc. stock deliver consistent dividendsTrade Entry Report & Expert Curated Trade Setup Alerts - newser.com
Will CytomX Therapeutics Inc. stock see insider buyingEarnings Overview Summary & Low Risk High Reward Ideas - newser.com
Why CytomX Therapeutics Inc. (6C1) stock gets analyst attentionExit Point & High Accuracy Buy Signal Tips - newser.com
CTMX (CytomX Therapeutics) Price-to-Operating-Cash-Flow : (As of Nov. 20, 2025) - GuruFocus
CytomX at Jefferies Conference: Promising Cancer Treatment Insights By Investing.com - Investing.com Canada
CytomX Therapeutics stock holds Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Canada
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):